Under the acquisition, Solna, Sweden-based Meda became a controlled subsidiary of Mylan. Mylan President Rajiv Malik said the acquisition will expand its over-the-counter business by $1 billion and will help the company expand into China, Southeast Asia, Russia and Middle East markets.
“This transaction also is extremely compelling financially, providing significant accretion to Mylan’s adjusted earnings per share, the opportunity for substantial synergies and further acceleration of our growth,” Mylan CEO Heather Bresch said in a statement.
More articles about supply chain:
CVS scraps coverage of 2 brand-name biotech drugs for biosimilars
Drug company drives $48k brain-eating amoeba treatment to SC hospital
Transforming data into insights that drive better outcomes
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
